RA Capital Management »

Alto Neuroscience shares owned by RA Capital Management

Quarter-by-quarter ownership of Alto Neuroscience shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 1.4M 15.35

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Legend Biotech Corp- SH (LEGN)
Janux Therapeutics SH (JANX)
Aerovate Therapeutics SH (AVTE)
Rhythm Pharmaceuticals SH (RYTM)
Evolent Health Inc - A SH (EVH)
Newamsterdam Pharma Co Nv SH (NAMS)
Rxsight SH (RXST)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
4d Molecular Therapeutics In SH (FDMT)
Biogen SH (BIIB)
Pepgen SH (PEPG)
Geron Corp SH (GERN)

View all positions for RA Capital Management

Top funds holding Alto Neuroscience

FMR
RA Capital Management
Point72 Asset Management
72 Investment Holdings
T. Rowe Price Associates
Franklin Resources
ExodusPoint Capital Management
Vanguard Group
Jennison Associates
Artal Group
Board of Trustees of The Leland Stanford Junior University
AWM Investment Company
Citadel Advisors
Valor Management
BlackRock

View all funds holding Alto Neuroscience